Cediranib Maleate and Selumetinib Sulfate in Treating Patients With Solid Malignancies
Condition(s):Metastatic Melanoma; Refractory Malignant Solid Neoplasm; Stage IV Cutaneous Melanoma AJCC v6 and v7; Unresectable Malignant Solid NeoplasmLast Updated:March 12, 2024Active, not recruiting